Results 331 to 340 of about 249,373 (343)

Cost-Effectiveness of Left Ventricular Assist Device for Transplant-Ineligible Patients.

JAMA Netw Open
Schaffer EM, Su RGS, Chay J, Finkelstein EA.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The novel ProtekDuo ventricular assist device: Configurations, technical aspects, and present evidence

Perfusion, 2022
The ProtekDuo, single site dual lumen cannula can be used in a multitude of configurations. In the medical literature, the ProtekDuo is described as right ventricular assist device (RVAD), as left ventricular assist device (LVAD), as biventricular assist
M. Maybauer, M. Koerner, J. Swol, A. El Banayosy, D. Maybauer   +4 more
semanticscholar   +1 more source

Right Ventricular Failure Post-Implantation of Left Ventricular Assist Device: Prevalence, Pathophysiology, and Predictors.

ASAIO journal (1992), 2020
Despite advances in left ventricular assist device (LVAD) technology, right ventricular failure (RVF) continues to be a complication after implantation. Most patients undergoing LVAD implantation have underlying right ventricular (RV) dysfunction (either
H. Ali, M. Kiernan, G. Choudhary, D. Levine, N. Sodha, A. Ehsan, R. Yousefzai   +6 more
semanticscholar   +1 more source

Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review

JAMA cardiology, 2018
Importance The mortality rate for the most advanced forms of heart failure with medical therapy alone remains unacceptably high at 30% to 80% at 1 year.
L. Miller, J. Rogers
semanticscholar   +1 more source

Less invasive left ventricular assist device implantation may reduce right ventricular failure.

Interactive Cardiovascular and Thoracic Surgery, 2019
OBJECTIVES Right ventricular (RV) failure after left ventricular assist device (LVAD) implantation continues to be a morbid complication. In this study, we hypothesized that a less invasive approach to implantation would preserve RV function relative to ...
C. Pasrija, Mariem A Sawan, E. Sorensen, H. Voorhees, Aakash Shah, E. Strauss, V. Ton, Laura DiChiacchio, D. Kaczorowski, B. Griffith, S. Pham, Z. Kon   +11 more
semanticscholar   +1 more source

Treatment of chronic left ventricular assist device infection with local application of bacteriophages.

European Journal of Cardio-Thoracic Surgery, 2019
Left ventricular assist device-associated infections represent a major complication during long-term support. Driveline exit site infections harbour the risk of ascending into the pump, causing deep-seated infections.
J. Mulzer, A. Trampuz, E. Potapov
semanticscholar   +1 more source

Minimally Invasive Left Ventricular Assist Device Implantation: A Comparative Study

Artificial Organs, 2018
Left ventricular assist device (LVAD) is now a routine therapy for advanced heart failure. Minimally invasive approach via thoracotomy for LVAD implantation is getting popular due to its potential advantage over the conventional sternotomy approach in ...
P. Mohite, A. Sabashnikov, B. Raj, R. Hards, G. Edwards, D. García-Sáez, B. Zych, M. Husain, A. Jothidasan, J. Fatullayev, M. Zeriouh, A. Weymann, A. Popov, F. de Robertis, A. Simon   +14 more
semanticscholar   +1 more source

Compassionate deactivation of ventricular assist devices in children: A survey of pediatric ventricular assist device clinicians’ perspectives and practices

Pediatric Transplantation, 2019
This study's objective was to investigate compassionate ventricular assist device deactivation (VADdeact) in children from the perspective of the pediatric heart failure provider.
B. Kaufman, S. Hollander, Yulin Zhang, Sharon Chen, D. Bernstein, D. Rosenthal, C. Almond, J. Murray, A. Burgart, H. Cohen, J. Kirkpatrick, E. Blume   +11 more
semanticscholar   +1 more source

Left Ventricular Assist Device: Indication, Timing, and Management.

Heart Failure Clinics, 2021
M. Frigerio
semanticscholar   +1 more source